- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05434117
Feasibility of High-Intensity Interval Nordic Walking in Patients With Coronary Artery Disease (HIIT-NoW)
Feasibility and Preliminary Efficacy of High-intensity Interval Nordic Walking in Patients With Coronary Artery Disease: A Pilot Randomized Clinical Trial (HIIT-NoW)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Coronary revascularization improves survival for patients with coronary artery disease (CAD). Despite successful coronary revascularization treatment, however, many patients with CAD are left suffering from poor exercise capacity and frequently experience difficulties in performing daily activities (e.g., getting dressed, sitting down or getting up from the toilet) because of diminished cardiovascular function and exercise tolerance. Decreased exercise capacity leads to a dramatic reduction in quality of life (QoL) and more severe depression symptoms. Low exercise capacity, poor quality of life (QoL) and severer depression symptoms heighten the risk of subsequent cardiovascular events and mortality.
Current guidelines recommend that persons with CAD who have undergone coronary artery bypass graft surgery (CABG) or percutaneous coronary intervention (PCI) participate in exercise-based cardiovascular rehabilitation (CR). Exercise-based CR is safe, effective and a class IA recommendation following CABG and PCI. Irrefutable evidence demonstrates that exercise-based CR including moderate-to-vigorous intensity continuous exercise training (MICT) improves exercise capacity, QoL, depression and reduces hospital readmissions and cardiovascular morbidity and mortality. MICT has long been used to manage the physical and mental health of CAD patients as per the Canadian Guidelines for Cardiovascular Rehabilitation and Cardiovascular Disease Prevention; however, such exercise may be less efficient and perceived as less motivating/enjoyable. Growing evidence suggests that non-conventional exercise interventions, such as high-intensity interval training (HIIT) and Nordic walking are more effective exercise modalities, and maybe more enjoyable, to improve clinical outcomes (e.g., exercise capacity, QoL, and depression symptoms) in patients with CAD.
HIIT (repeated bouts of brief high-intensity exercise interspersed with active recovery) is an effective and efficient exercise training paradigm. A recent meta-analysis (n=10 studies) comparing HIIT and MICT in patients with CAD suggests that: (1) HIIT is superior to MICT in improving cardiorespiratory fitness (V̇O2peak) of patients with CAD, an important clinical vital sign and strong predictor of mortality; and, (2) HIIT and MICT are equally effective in improving QoL and depression symptoms in patients including CAD. Increases in cardiorespiratory fitness decrease mortality risk -- every 3.5 ml/kg/min increase in V̇O2peak yields a 13% improvement in survival. Exercise training-induced increases in cardiorespiratory fitness are therefore highly desirable for the improvement of important patient outcomes.
Nordic walking is similar to Nordic skiing but uses specifically designed poles for walking. Nordic walking includes the recruitment of core, upper and lower body muscles, resulting in greater exergy expenditure while reducing loading stress at the knee joint. Regular participation in Nordic walking leads to increased exercise capacity. Although data is limited regarding the impact of Nordic walking in comparison to MICT on mental health in patients with CAD, some studies in patients with heart failure have shown superior improvements in QoL and fewer depressive symptoms following Nordic walking when compared to MICT. Our previous randomized controlled trial simultaneously comparing 12 weeks of supervised HIIT, MICT and Nordic walking in patients with CAD showed that Nordic walking was statistically and clinically superior in increasing functional capacity (i.e., distance walked over 6 minutes), and have similar effects on QoL and depression when compared to HIIT or MICT.
As many adults with cardiovascular disease consider lack of time a barrier to exercise, HIIT may be an appealing exercise training paradigm as cardiovascular health benefits can be achieved in less time when compared to MICT. HIIT may also address other frequently reported deterrents to MICT, including lack of interest and motivation, boredom, not challenging enough, and tailored for older people's needs. To date, HIIT used in CR settings has predominantly focused on lower body (e.g., leg cycling). There are few HIIT protocols that simultaneously target both upper and lower body, such as high-intensity interval Nordic walking (HIIT-NoW). Studies have shown that HIIT and Nordic walking are feasible, enjoyable and have similar or superior effects on physical and mental health when compared to MICT. By combining HIIT and Nordic walking, HIIT-NoW may offer an alternative time-efficient whole-body exercise to improve physical and mental health of patients with CAD.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1Y4W7
- University of Ottawa Heart Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- patients with coronary artery disease treated with PCI or CABG;
- willing to come onsite for exercise sessions;
- able to perform a cardiopulmonary exercise testing (CPET); and,
- at least 40 years of age.
Exclusion Criteria:
- currently participating in a CR program;
- unstable angina or established diagnosis of atrial fibrillation, chronic obstructive pulmonary disease, severe mitral or aortic stenosis, or hypertrophic obstructive cardiomyopathy; or,
- unable to return for 10-week follow-up visit.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High-intensity interval Nordic walking
Participants will receive high-intensity interval Nordic walking training.
|
Participants will complete supervised exercise sessions twice weekly for 10 weeks.
Exercise specialists will educate participants in proper use of walking poles and basic Nordic walking techniques and supervise the exercise training sessions.
HIIT-NoW will be 45 min in duration using Nordic poles and consists of (i) a 10-min warm-up at 30-59% heart rate reserve (HRR, light-to-moderate intensity); (ii) 4 × 4 min of high-intensity work periods at 60-89% HRR (vigorous intensity) interspersed with 3 min of low-intensity work periods at 30-59% HRR (light-to-moderate intensity); and, (iii) a 10-min cooldown at 30-39% HRR (light intensity).
To allow participants to acclimatize to the HIIT-NoW protocol, the training intensity will target 60-69% HRR for the first week, 70-79% HRR in the second week, and 80-89% HRR from the third week onward.
If participants do not tolerate 89% HRR well, they will exercise as close to 89% HRR as possible.
|
|
Active Comparator: Control
Participants will undergo standard cardiovascular rehabilitation.
|
Individuals assigned to standard CR will attend onsite exercise-based CR comprised of one onsite exercise session per week for 8-10 weeks.
The onsite CR offers exercise sessions tailored to the fitness of patients and strengthening exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment
Time Frame: Baseline to week 11 follow up
|
Recruitment will be assessed for feasibility.
Recruitment will be assessed by the proportion of patients remained interested and randomized after being informed of the requirements of the study
|
Baseline to week 11 follow up
|
|
Adherence
Time Frame: Baseline to week 11 follow up
|
Adherence will be assessed for feasibility.
Adherence will be assessed by the attendance to the prescribed exercise sessions
|
Baseline to week 11 follow up
|
|
Compliance
Time Frame: Baseline to week 11 follow up
|
Compliance will be assessed for feasibility.
Compliance will be assessed by the proportion of participants adhering to prescribed exercise intensity.
All HIIT-NoW sessions will be monitored by study personnel and compliance to prescribed exercise intensity will be assessed for each exercise session.
|
Baseline to week 11 follow up
|
|
Adverse events
Time Frame: Baseline to week 11 follow up
|
Safety will be assessed for feasibility.
All mild, moderate, and severe symptoms and adverse events throughout this study will be recorded.
|
Baseline to week 11 follow up
|
|
Subjective exercise experiences
Time Frame: Baseline to week 11 follow up
|
Subjective exercise experiences will be assessed for feasibility.
Physical activity enjoyment will be collected using the PACES.
|
Baseline to week 11 follow up
|
|
Self-efficacy
Time Frame: Baseline to week 11 follow up
|
Self-efficacy will be assessed for feasibility.
Exercise self-efficacy will be assessed using the MSES-R.
|
Baseline to week 11 follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiorespiratory fitness
Time Frame: Baseline to week 11 follow up
|
Cardiorespiratory fitness (V̇O2peak) will be measured by a symptom-limited CPET.
|
Baseline to week 11 follow up
|
|
Functional capacity
Time Frame: Baseline to week 11 follow up
|
Functional capacity will be assessed by the 6-minute walk test.
|
Baseline to week 11 follow up
|
|
Fat mass
Time Frame: Baseline to week 11 follow up
|
Fat mass (kg) will be measured using bioelectrical impedance analysis.
|
Baseline to week 11 follow up
|
|
Quality of life (QoL)
Time Frame: Baseline to week 11 follow up
|
General Quality of life will be assessed using the Medical Outcomes Study Short Form-36.
Higher scores indicate better QoL
|
Baseline to week 11 follow up
|
|
Heart Disease specific Quality of life (HeartQoL)
Time Frame: Baseline to week 11 follow up
|
Heart Disease specific Quality of life (HeartQoL) will be assessed using the disease-specific quality of life questionnaire.
Higher scores indicate better HeartQoL (0-3 points).
|
Baseline to week 11 follow up
|
|
Depression
Time Frame: Baseline to week 11 follow up
|
Depression: will be assessed by the Beck Depression Inventory-II.
Higher scores indicate more severe depression symptoms.
|
Baseline to week 11 follow up
|
|
Gender
Time Frame: Baseline to week 11 follow up
|
Gender: will be assessed using the Genesis-Praxy questionnaire.
|
Baseline to week 11 follow up
|
|
Physical activity levels
Time Frame: Baseline to week 11 follow up
|
Physical activity levels: Participants will wear a activity monitor (Actigraph GT3X) over the right hip for a week at baseline and follow-up.
|
Baseline to week 11 follow up
|
|
Subjective functinal capacity
Time Frame: Baseline to week 11 follow up
|
Subjective functional capacity will be assessed by the Duke Activity Status Index questionnaire.
|
Baseline to week 11 follow up
|
|
Fat-free mass
Time Frame: Baseline to week 11 follow up
|
Fat-free mass (kg) will be measured using bioelectrical impedance analysis.
|
Baseline to week 11 follow up
|
|
Waist circumference
Time Frame: Baseline to week 11 follow up
|
Waist circumference (cm) will be measured by standardized procedures using a Seca tape measure.
|
Baseline to week 11 follow up
|
|
Blood pressure
Time Frame: Baseline to week 11 follow up
|
Resting blood pressure will be measured in a seated position after a 5-minute rest period using an automated monitor.
|
Baseline to week 11 follow up
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jennifer L Reed, PhD, Ottawa Heart Institute Research Corporation
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20220260
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
Mahidol UniversityThe Princess Mantarop Kamalas Foundation, The Nurses' Association of Thailand and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Postoperative Recovery | Coronary Artery Bypass Graft (CABG)Thailand
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
Clinical Trials on High-intensity interval Nordic walking
-
Ottawa Heart Institute Research CorporationOntario Ministry of Health and Long Term Care; Heart and Stroke Foundation...CompletedCoronary Artery Disease (CAD)Canada
-
University of VirginiaCompletedCardiovascular Diseases | Breast Cancer | CardiotoxicityUnited States
-
Universidad SurcolombianaMaciste Macias; Gilberto AstaizaRecruiting
-
University of MichiganCompletedGlucose IntoleranceUnited States
-
Kuopio Research Institute of Exercise MedicineKuopio University Hospital; University of Basel; University of Eastern Finland; Social Insurance Institution, FinlandTerminatedUnstable Angina Pectoris | Acute Myocardial Infarction | Recurrent Myocardial InfarctionFinland
-
University of GuelphCompletedPost-Exercise Hypotension | Ambulatory Blood Pressure Monitoring | High-intensity Interval ExerciseCanada
-
Riphah International UniversityCompleted
-
Cairo UniversityKasr El Aini HospitalCompletedDiabetes Mellitus, Type 2Egypt
-
Universidad Santo TomasCompletedMetabolic DiseasesColombia